Hoffman Robert E. 4
4 · CytoDyn Inc. · Filed May 22, 2025
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
Hoffman Robert E.
Chief Financial Officer
Transactions
- Award
Non-qualified stock option (right to buy)
2025-05-15+1,000,000→ 1,000,000 totalExercise: $0.41Exp: 2035-05-15→ Common Stock (1,000,000 underlying)
Footnotes (2)
- [F1]This grant was approved by the Company's Compensation Committee effective May 15, 2025, pursuant to the Issuer's 2012 Equity Incentive Plan, as amended (the "Plan").
- [F2]250,000 shares will vest on May 15, 2026, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Plan ) from May 2026 through April 2029.